Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Humacyte Inc.

www.humacyte.com

Latest From Humacyte Inc.

'Pharma Fireworks': Pipeline Catalysts To Watch Out For In Q2

Scrip looks at some the key clinical and regulatory pharma events that will spark attention during the next three months, according to Biomedtracker's latest quarterly outlook report.

Clinical Trials Drug Review

Eight Pivotal Trial Read-Outs Expected In Q3

A number of pivotal studies are expected to report top-line data in the third quarter. Here, with the help of Informa Pharma's Biomedtracker, we take a look at eight of those likely to be major catalysts for their sponsors.

Clinical Trials Research & Development

Venture Funding Deals: MedImmune Spinout Viela Lands $250m Series A

China's JW Therapeutics nets $90m for cancer cell therapy, including backing from biotechs Celgene and WuXi. Meanwhile, Foghorn sounds out a $50m A round for its gene trafficking technology applications.

Deals Financing

RMAT Designation, Gene Therapies Highlight 2017 CBER Transformation

CBER Director Peter Marks says the center implemented a lot in a short amount of time for the RMAT pathway.

Biologics Drug Review
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Humacyte Inc.
  • Senior Management
  • Jeffrey Lawson, MD, PhD, Pres. & CEO
    Douglas Blankenship, CFO
    Theodore D Lithgow, PhD, COO
    Chris Fang, MD, CMO
  • Contact Info
  • Humacyte Inc.
    Phone: (919) 313-9633
    2525 E NC Highway 52
    Durham, NC 27713
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register